No Data
No Data
Castle Biosciences Hosts Groundbreaking Ceremony at Site of New Corporate Headquarters in Friendswood, Texas
New Data at AFS 2024 Demonstrates the Strength of Castle Biosciences' TissueCypher Test in Independently Predicting Risk of Developing Esophageal Cancer, Guiding Risk-Aligned Management Decisions for Patients With Barrett's Esophagus
Castle Biosciences CEO Sells Over $158k in Company Stock
Express News | Castle Biosciences’ Chief Operating Officer Kristen Oelschlager Named Arizona Bioscience Leader of the Year
Castle Biosciences' Chief Operating Officer Kristen Oelschlager Named Arizona Bioscience Leader of the Year
Castle Biosciences (NASDAQ:CSTL) Is Using Debt Safely